Clinical Trial Update: Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating paclitaxel in combination with a monoclonal antibody for recurrent or metastatic breast cancer has completed. The document provides a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Monoclonal antibody therapy
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED